Romazicon (Flumazenil) - Summary

ROMAZICON SUMMARY

ROMAZICON® (flumazenil) is a benzodiazepine receptor antagonist.

ADULT PATIENTS

ROMAZICON is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose.

PEDIATRIC PATIENTS (AGED 1 TO 17)

ROMAZICON is indicated for the reversal of conscious sedation induced with benzodiazepines (see PRECAUTIONS: Pediatric Use).

See all Romazicon indications & dosage >>

ROMAZICON NEWS HIGHLIGHTS

Published Studies Related to Romazicon (Flumazenil)

Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing. [2007.01]

Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial. [2006.10]

Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. [2005.03]

Effect of flumazenil on recovery from sevoflurane anesthesia in children premedicated with oral midazolam before undergoing herniorrhaphy with or without caudal analgesia. [2005]

Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females. [2004.03]

more >>

Clinical Trials Related to Romazicon (Flumazenil)

Rapid Benzodiazepine Detoxification Using Flumazenil - 1 [Completed]

Rapid Benzodiazepine Detoxification Using Flumazenil - 2 [Completed]

Flumazenil Reversal of Oral Triazolam [Completed]

Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325 [Recruiting]

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280 [Recruiting]

more >>